This comprehensive report contains 406 pages, 38 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the German coagulation testing market during the next five years.

The report explores business and technological trends in the German coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand’s Factor Fav/Ag, and others.

Sales and Market Share Analysis

Sales and market shares of major instrument and reagent suppliers.

Competitive Assessments

Extensive strategic profiles of major suppliers and emerging market entrants.

Market Segmentation Analysis

Comprehensive market segmentation analysis, including:

• Hospitals
• Commercial/Private Laboratories
• Physician Offices

Test volume forecasts for over 40 major procedures by market segment.

Current and Emerging Products

• Review of established and emerging procedures.
• Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review

• Analysis of current and emerging technologies and their potential market applications.
• Comprehensive lists of companies developing or marketing new technologies and prodcts by test.

Strategic Recommendations

• Product development and business expansion opportunities with significant market appeal.
• “Ideal” product models with tentative prices and operating characteristics.
• Alternative market penetration strategies for instrument and reagent suppliers.
• Potential market entry barriers and risks.

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrand's Factor
B. Instrumentation Review
C. Major in VitrDiagnostic Technologies and Their Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
4. Molecular Diagnostics
5. Microcomputers
6. Automation
7. Robotics
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors

III. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument and Reagent Suppliers' Sales and Market Shares

X. Major Product Development Opportunities

XI. Design Criteria For Decentralized Testing Products

XII. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation

XIII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XIV. Competitive Assessments
- Abbott
- ADI/American Diagnostic
- Axis-Shield
- Alere/Biosite/Inverness
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio/Data Corporation
- Chrono-Log
- Corgenix Medical
- Diagnostica Stago/Trinity Biotech
- Helena Laboratories
- HYPEN BioMed
- Instrumentation Laboratory
- ITC
- Roche
- Siemens
- Sienco
- Sysmex
- ThermFischer
- ZyCare/Alere

List of Tables

Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests

Executive Summary Table: Germany, Total Coagulation Diagnostics Market By Market Segment and Product Category
Germany, Laboratories Performing Coagulation Tests By Market Segment
Germany, Hospital Laboratories Performing Coagulation Tests By Bed Size
Germany, Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume
Germany, Hospital Laboratories Average Daily Test Volume
Germany, Commercial/Private Laboratories Average Daily Test Volume
Germany, Physician Offices/Group Practice Average Daily Test Volume
Germany, Total Coagulation Test Volume By Market Segment
Germany, All Market Segments Coagulation Test Volume
Germany, Hospital Laboratories Coagulation Test Volume
Germany, Commercial/Private Laboratories Coagulation Test Volume
Germany, Physician Offices/Group Practices Coagulation Test Volume
Germany, Coagulation Reagent Market By Market Segment
Germany, Major Suppliers of Coagulation Reagents, Estimated Sales and Market Shares
Germany, Coagulation Instrument Market By Market Segment
Germany, Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares
Germany, Total Coagulation Diagnostics Market By Product Category
Germany, Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares